Published in Cancer Weekly, January 4th, 2005
The work was part of Laura Bungener's doctoral research. Her supervisor was Prof. J.C. Wilschut, RUG, Medische Microbiologie.
The vaccines induce an immune response to proteins from the human papillomavirus (HPV) that causes cervical cancer, rendering the virus harmless. Laboratory animals that had already developed a tumor could be treated with a vaccination.
More than 100 types of HPV are known. Some of these are high-risk types of HPV, which can convert healthy cells into...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.